AmerisourceBergen Corporation company logo

# 1st Gen Model AmerisourceBergen Corporation Drugs, proprietaries, & sundries

Subscribe >> Deal exit on
July 21, 2017
Deal entry on
July 21, 2017
0.89%Expected margin
66.10% successful of 59 deals
$91.62 Last close price
at 21-jul-2017


Model's trade recommendations -3.61% Return for period

-10.23% Annual return

$19.91B Market Cap

β 0.91  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period -3.61%
52wk return -6.66%
52wk Range
Sortino ratio -0.71
Sharpe ratio -0.63
Norm. RMSE 0.32%
Downside risk 13.81%
Volatility 15.61%
  • 1.46 (1.60%) Div (Yield)
  • BUY Analysts consensus recommendation

AmerisourceBergen Corporation provides pharmaceutical services. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers. The Company also provides pharmacy services to certain specialty drug patients. AmerisourceBergen Corporation is based in Chesterbrook, Pennsylvania.

Industry sector: Medical

Sector classification: Drugs, proprietaries, & sundries

Deep Learning based analysis and prediction model for AmerisourceBergen Corporation (ABC) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for ABC model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 159M
P/E 15.72
Shares Outstanding 218M
% Held by Insiders 27.40%
% Held by Institutions 69.09%
EPS (last reported FY) $5.62
EPS (last reported Q) $1.77
EPS, estimated (last reported Q) $1.71
Total revenues $147 B
Net income $1 B